+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles



Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles



Nanomedicine 10(3): 651-660



Nanoparticles offer new options for medical diagnosis and therapeutics with their capacity to specifically target cells and tissues with imaging agents and/or drug payloads. The unique physical aspects of nanoparticles present new challenges for this promising technology. Studies indicate that nanoparticles often elicit moderate to severe complement activation. Using human in vitro assays that corroborated the mouse in vivo results we previously presented mechanistic studies that define the pathway and key components involved in modulating complement interactions with several gadolinium-functionalized perfluorocarbon nanoparticles (PFOB). Here we employ a modified in vitro hemolysis-based assay developed in conjunction with the mouse in vivo model to broaden our analysis to include PFOBs of varying size, charge and surface chemistry and examine the variations in nanoparticle-mediated complement activity between individuals. This approach may provide the tools for an in-depth structure-activity relationship study that will guide the eventual development of biocompatible nanoparticles. Unique physical aspects of nanoparticles may lead to moderate to severe complement activation in vivo, which represents a challenge to clinical applicability. In order to guide the eventual development of biocompatible nanoparticles, this team of authors report a modified in vitro hemolysis-based assay developed in conjunction with their previously presented mouse model to enable in-depth structure-activity relationship studies.

(PDF emailed within 0-6 h: $19.90)

Accession: 051607281

Download citation: RISBibTeXText

PMID: 24211337

DOI: 10.1016/j.nano.2013.10.012



Related references

Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies. Nanoscale 7(14): 6045-6058, 2016

Electrophoretic mobility of complement c 1q is changed during activation of complement c 1 new assay for complement c 1q complement c 1s and complement c 1 inhibitor. Federation Proceedings 41(3): ABSTRACT 3375, 1982

Evaluation of zymosan induced complement activation by 50 percent complement hemolysis test. Farmaco Edizione Pratica 41(4): 147-154, 1986

Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay. Transfusion 56(7): 1845-1848, 2016

Qualitative analysis of total complement activation by nanoparticles. Methods in Molecular Biology 697: 237-245, 2011

A simple one-step hemolytic assay of the first component of human complement (C1) with polyethylene glycol treated human serum: details of the assay procedures and its application to the C1 activation study. Journal of Clinical & Laboratory Immunology 21(3): 141-146, 1986

Complement c 3 independent immune hemolysis hemolysis of eac 14o x y 2 cells by complement c 5 c 9 without participation of complement c 3. Immunology 53(3): 575-582, 1984

Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations. Biomaterials, Artificial Cells, and Artificial Organs 16(1-3): 431-438, 1988

Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity. IEEE Transactions on Nanobioscience 5(2): 69-75, 2006

Mechanism Of Hemolysis By Complement : I. Complement Fixation As An Essential Preliminary To Hemolysis. Journal of General Physiology 12(6): 845-862, 1929

Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum. Journal of Clinical Investigation 73(1): 160-170, 1984

Hemolysis with human complement, human cells, and tannic acid; application to complement fixation test. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 67(4): 475-478, 1948

Complement c 3 activation in serum quantitative analysis of the generation of complement c 3a complement c 3b c and complement c 3d g as measured by specific radioimmunoassays. Complement 2(1): 31, 1985

The time of hemolysis in the complement-fixation reactions Quantitative relations between time of hemolysis and concentration of complement in the hemolytic anti-sheep system. 1949

One point method for the assay of the alternative complement pathway hemolysis in rats. Kawasaki Medical Journal 11(4): 215-218, 1985